Valproate, an antiepileptic agent that is often prescribed for psychiatric conditions, is associated with weight gain when prescribed in high doses, new data suggest.
Infectious disease experts share why they think more than 2 years of COVID-19 helped create a treacherous environment for unusual RSV and flu outbreaks.